Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,385 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Reply.
Weiner A, Chan W, Zhang C, Mittal A, Fink A, Michalovic S. Weiner A, et al. Among authors: fink a. Ophthalmol Glaucoma. 2024 Nov-Dec;7(6):e7-e8. doi: 10.1016/j.ogla.2024.08.007. Epub 2024 Oct 5. Ophthalmol Glaucoma. 2024. PMID: 39373681 No abstract available.
Dynamic switching between brain networks predicts creative ability.
Chen Q, Kenett YN, Cui Z, Takeuchi H, Fink A, Benedek M, Zeitlen DC, Zhuang K, Lloyd-Cox J, Kawashima R, Qiu J, Beaty RE. Chen Q, et al. Among authors: fink a. Commun Biol. 2025 Jan 15;8(1):54. doi: 10.1038/s42003-025-07470-9. Commun Biol. 2025. PMID: 39809882 Free PMC article.
Do you know your PSMA-tracer? Variability in the biodistribution of different PSMA ligands and its potential impact on defining PSMA-positivity prior to PSMA-targeted therapy.
Heilinger J, Roth KS, Weis H, Fink A, Weindler J, Dietlein F, Krapf P, Schomäcker K, Neumaier B, Dietlein M, Drzezga A, Kobe C. Heilinger J, et al. Among authors: fink a. EJNMMI Res. 2025 Jan 10;15(1):4. doi: 10.1186/s13550-024-01190-7. EJNMMI Res. 2025. PMID: 39792324 Free PMC article.
Clinical Implementation of a High-Throughput Automated Comprehensive Genomic Profiling Test: TruSight Oncology 500 HT.
Ball M, Romanovsky E, Schnecko F, Kirchner M, Neumann O, Brandt R, Beck S, Seker-Cin H, Kluck K, Ourailidis I, Goldschmid H, Fink A, Volckmar AL, Menzel M, Allgäuer M, Schirmacher P, Budczies J, Stenzinger A, Kazdal D. Ball M, et al. Among authors: fink a. J Mol Diagn. 2024 Dec 12:S1525-1578(24)00305-2. doi: 10.1016/j.jmoldx.2024.11.005. Online ahead of print. J Mol Diagn. 2024. PMID: 39674366 Free article.
Ibrutinib in Early-Stage Chronic Lymphocytic Leukemia: The Randomized, Placebo-Controlled, Double-Blind, Phase III CLL12 Trial.
Langerbeins P, Robrecht S, Nieper P, Cramer P, Fürstenau M, Al-Sawaf O, Simon F, Fink AM, Kreuzer KA, Vehling-Kaiser U, Tausch E, Schneider C, Müller L, Eckart MJ, Schlag R, Freier W, Gaska T, Balser C, Reiser M, Stauch M, Zahn MO, Dörfel S, Staib P, Behlendorf T, Hensel M, Hebart H, Klaproth H, Block A, Liersch R, Hauch U, Heinrich B, Wendtner CM, Fischer K, Stilgenbauer S, Eichhorst B, Hallek M. Langerbeins P, et al. Among authors: fink am. J Clin Oncol. 2024 Nov 27:JCO2400975. doi: 10.1200/JCO.24.00975. Online ahead of print. J Clin Oncol. 2024. PMID: 39602678
1,385 results